ISRCTN32129167已完成不适用
Hypnosis and self-hypnosis, administered and taught by nurses, for the reduction of chronic pain: a controlled clinical trial
Hospital of Morges (Switzerland)0 个研究点目标入组 130 人开始时间: 2005年10月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. To be referred (including occasional self-referral) for the management of chronic pain
- •2. To live within manageable distances from the hospital
- •3. To be aged 18 or above
- •4. To understand and speak French adequately
- •5. To be able to see, hear and communicate (i.e. no alteration of consciousness)
- •6. To have no diagnosis of mental illness (e.g. psychosis)
- •7. To give informed consent
排除标准
- •Patients were excluded from the study whenever they wished and/or when no conventional treatment could be proposed.
研究者
相似试验
招募中
4 期
ow-dose naltrexone as an adjunctive treatment in major depressive disorder.Major depressive disorder (MDD)Mental Health - DepressionACTRN12622000881730niversity of Auckland72
招募中
1 期
A study to evaluate efficacy and safety of Orally Administered Extract of Orthosiphon stamineus (Nuvastaticâ?¢ - C5OSEW5050ESA) for 12 months in Patients With Non-proliferative Diabetic Retinopathy Without Center-involved Diabetic Macular Edema.CTRI/2019/10/021540atureceuticals Sdn Bhd
进行中（未招募）
不适用
IMRAD: A randomised placebo-controlled trial of synchronous NIMorazole versus RADiotherapy alone in patients with locally advanced head and neck squamous cell carcinoma not suitable for synchronous chemotherapy or cetuximabEUCTR2013-002466-39-GBThe Christie NHS Foundation Trust470
已完成
不适用
*A randomized, double-blind, placebo-controlled Phase I study to evaluate the safety and tolerability of intrathecally administered single ascending bolus doses of Xen2174 in healthy subjects*PijnPainNL-OMON32600Xenome Ltd.35
进行中（未招募）
1 期
To see how the medication MED2005 works (i.e. causes an erection) when applied to the penis by male volunteers who normally are unable to obtain an erectioThis study investigates a drug intended for the treatment of male patients self-diagnosed with Erectile DysfunctionMedDRA version: 18.1Level: PTClassification code 10061461Term: Erectile dysfunctionSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2014-005571-89-PLFutura Medical Developments Ltd.192